SPECT diagnostic (Fujifilm RI Pharma)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSPECT diagnostic (Fujifilm RI Pharma)
Drug Alias NameIodine-123-DRM-106Iodine-125-DRM-106125I-DRM-106123I-DRM-106DRM-106-[123I] +[6] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)
Mechanisms of ActionSPECT contrast agentBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujifilm Toyama Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujifilm Toyama Chemical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A